Dr. Viktor von Wyl
- Position
- Wissenschaftlicher Mitarbeiter
am CSS Institut für empirische Gesundheitsökonomie
Tribschenstrasse 21
CH-6002 Luzern
- 1984-1996
- Schulen in Sarnen, Obwalden
- 1996-2002
- Studium der Biologie und der Volkswirtschaftslehre, Universität Basel
- 2005-2008
- Dissertation zu Epidemiologie, Entstehung und Behandlung von Resistenzen gegen HIV Therapien am Universitätsspital Zürich und der ETH Zürich
- 2002-2004
- Datenmanager/Analyst für die Women's Interagency HIV Study (WIHS) an der Georgetown University, Washington DC, USA
- 2004-2010
- Wissenschaftlicher Mitarbeiter an der Klinik für Infektionskrankheiten und Spitalhygiene, Universitätsspital Zürich
- Seit 2008
- Dozent an der Medizinischen Fakultät der Universität Zürich im Rahmen des Mantelstudium-Kurses "Informatik in der Medizin"
- 2010-2011
- Gast-Forscher in der HIV Clinical Epidemiology and Biostatistics Group, University College London, UK
- von Wyl, Viktor, Sabine Yerly, et al. (2007): "Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types", in: Archives of Internal Medicine; 167(16), p. 1782-90
-
von Wyl, Viktor, Sabine Yerly, et al. (2009): "Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland", in: Clinical Infectious Diseases; 48(7), p. 979-87
-
von Wyl, Viktor, Maryam Ehteshami, et al. (2010): "HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy", in: Clinical Infectious Diseases; 51(5), p. 620-8
-
von Wyl, Viktor, Roger D. Kouyos, et al. (2011): " The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in Switzerland", in: Journal of Infectious Diseases; 204(7), p. 1095-1103
-
von Wyl, Viktor, Sabine Yerly, et al.: "Incidence of HIV-1 Drug Re-sistance Among Antiretroviral Treatment Naive Individuals Starting Modern Therapy Combinations", in: Clinical Infectious Diseases; in press.
-
von Wyl, Viktor, Valentina Cambiano, et al. "Simulation of inclusion of tenofovir instead of zidovudine for firstline antiretroviral therapy in settings without virological monitoring: Emerging resistance patterns and implications for cost-effectiveness", submitted.